FDA Inspection 1055849 — Eunice S. Wang, M.D.
The FDA completed an inspection of Eunice S. Wang, M.D. on Jun 5, 2018 in Buffalo, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 5, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Buffalo, NY (United States)
Additional details
Clinical Investigator (CI)